Primary Cells

Human Acute Lymphoid Leukemia PB Plasma (Relapsed/Refractory)

  • For research use only

Cat No.

ABC-TC3012

Product Type

Blood Products

Cell Type

Plasma

Species

Human

Growth Conditions

37 ℃, 5% CO2

Source Organ

Peripheral Blood

Disease

Acute Lymphoid Leukemia

Storage

Liquid Nitrogen

Human Acute Lymphoid Leukemia PB Plasma (Relapsed/Refractory) is ideal for biomarker profiling, cytokine quantification, and leukemia progression tracking.

Product Image

Description

Human Acute Lymphoid Leukemia Peripheral Blood Plasma is an acellular plasma fraction isolated from peripheral blood of adult Homo sapiens patients with relapsed or refractory acute lymphoid leukemia (ALL), predominantly B-ALL with occasional T-ALL cases. This clear, cell-free plasma contains leukemia-associated soluble mediators and circulating extracellular vesicles, reflecting the altered systemic microenvironment of treatment-resistant leukemia and supporting studies of genetic markers in refractory ALL plasma, novel treatments targeting PB plasma in leukemia, and therapy response markers in ALL plasma. To ensure the quality of these primary cells, repeated freeze-thaw cycles are not recommended due to the fragile nature of these cells. Each lot undergoes rigorous screening and isolation procedures, and is rigorously tested to ensure it is free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.

Product Code

Human Acute Lymphoid Leukemia PB Plasma (Relapsed/Refractory), ALL PB plasma R/R, Human ALL PB plasma R/R

Species

Human

Cat.No

ABC-TC3012

Product Category

Primary Cells

Size/Quantity

1 vial

Cell Type

Plasma

Shipping Info

Dry Ice

Growth Conditions

37 ℃, 5% CO2

Source Organ

Peripheral Blood

Disease

Acute Lymphoid Leukemia

Biosafety Level

1

Storage

Liquid Nitrogen

Product Type

Blood Products

Quality Control

All cells test negative for mycoplasma, bacteria, yeast, and fungi.

Application

  • This peripheral blood plasma is an optimal sample type for studying leukemic relapse mechanisms, systemic cytokine imbalances, and the biomolecular content of circulating EVs. It supports applications in liquid biopsy development, cfDNA/cfRNA mutation profiling, and validation of relapse biomarkers. Suitable for technologies including qPCR, FISH, ELISA, NGS, proteomics, and immunoassays, it enables both fundamental and translational research targeting therapeutic resistance, minimal residual disease, and the leukemic niche in relapsed/refractory ALL.

Citation

When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).

Inquiring Human Acute Lymphoid Leukemia PB Plasma (Relapsed/Refractory)

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research

Tags

AcceGen Scroll Top Button